246 related articles for article (PubMed ID: 29322326)
1. Heparan sulfate accumulation and perlecan/HSPG2 up-regulation in tumour tissue predict low relapse-free survival for patients with glioblastoma.
Kazanskaya GM; Tsidulko AY; Volkov AM; Kiselev RS; Suhovskih AV; Kobozev VV; Gaytan AS; Aidagulova SV; Krivoshapkin AL; Grigorieva EV
Histochem Cell Biol; 2018 Mar; 149(3):235-244. PubMed ID: 29322326
[TBL] [Abstract][Full Text] [Related]
2. Chondroitin sulfate content and decorin expression in glioblastoma are associated with proliferative activity of glioma cells and disease prognosis.
Tsidulko AY; Kazanskaya GM; Volkov AM; Suhovskih AV; Kiselev RS; Kobozev VV; Gaytan AS; Krivoshapkin AL; Aidagulova SV; Grigorieva EV
Cell Tissue Res; 2020 Jan; 379(1):147-155. PubMed ID: 31773303
[TBL] [Abstract][Full Text] [Related]
3. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
[TBL] [Abstract][Full Text] [Related]
4. Heparan Sulfate Biosynthetic System Is Inhibited in Human Glioma Due to EXT1/2 and HS6ST1/2 Down-Regulation.
Ushakov VS; Tsidulko AY; de La Bourdonnaye G; Kazanskaya GM; Volkov AM; Kiselev RS; Kobozev VV; Kostromskaya DV; Gaytan AS; Krivoshapkin AL; Aidagulova SV; Grigorieva EV
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29104277
[TBL] [Abstract][Full Text] [Related]
5. Ablation of Perlecan Domain 1 Heparan Sulfate Reduces Progressive Cartilage Degradation, Synovitis, and Osteophyte Size in a Preclinical Model of Posttraumatic Osteoarthritis.
Shu CC; Jackson MT; Smith MM; Smith SM; Penm S; Lord MS; Whitelock JM; Little CB; Melrose J
Arthritis Rheumatol; 2016 Apr; 68(4):868-79. PubMed ID: 26636652
[TBL] [Abstract][Full Text] [Related]
6. Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
Tsidulko AY; Kazanskaya GM; Kostromskaya DV; Aidagulova SV; Kiselev RS; Volkov AM; Kobozev VV; Gaitan AS; Krivoshapkin AL; Grigorieva EV
Tumour Biol; 2017 Sep; 39(9):1010428317724282. PubMed ID: 28945172
[TBL] [Abstract][Full Text] [Related]
7. Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation.
Tran-Lundmark K; Tran PK; Paulsson-Berne G; Fridén V; Soininen R; Tryggvason K; Wight TN; Kinsella MG; Borén J; Hedin U
Circ Res; 2008 Jul; 103(1):43-52. PubMed ID: 18596265
[TBL] [Abstract][Full Text] [Related]
8. Heparan sulfate proteoglycan expression in chronic cholestatic human liver diseases.
Roskams T; Rosenbaum J; De Vos R; David G; Desmet V
Hepatology; 1996 Sep; 24(3):524-32. PubMed ID: 8781318
[TBL] [Abstract][Full Text] [Related]
9. Chemoradiotherapy Increases Intratumor Heterogeneity of HPSE Expression in the Relapsed Glioblastoma Tumors.
Suhovskih AV; Kazanskaya GM; Volkov AM; Tsidulko AY; Aidagulova SV; Grigorieva EV
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075104
[TBL] [Abstract][Full Text] [Related]
10. Elevated hypertrophy, growth plate maturation, glycosaminoglycan deposition, and exostosis formation in the
Shu CC; Smith SM; Little CB; Melrose J
Biochem J; 2019 Jan; 476(2):225-243. PubMed ID: 30563944
[TBL] [Abstract][Full Text] [Related]
11. Perlecan heparan sulfate deficiency impairs pulmonary vascular development and attenuates hypoxic pulmonary hypertension.
Chang YT; Tseng CN; Tannenberg P; Eriksson L; Yuan K; de Jesus Perez VA; Lundberg J; Lengquist M; Botusan IR; Catrina SB; Tran PK; Hedin U; Tran-Lundmark K
Cardiovasc Res; 2015 Jul; 107(1):20-31. PubMed ID: 25952902
[TBL] [Abstract][Full Text] [Related]
12. Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin.
Han J; Hiebert LM
Vascul Pharmacol; 2013; 59(3-4):112-8. PubMed ID: 23939434
[TBL] [Abstract][Full Text] [Related]
13. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
Vischer P; Feitsma K; Schön P; Völker W
Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
[TBL] [Abstract][Full Text] [Related]
14. Heparan sulfate proteoglycan expression in human lung-cancer cells.
Nackaerts K; Verbeken E; Deneffe G; Vanderschueren B; Demedts M; David G
Int J Cancer; 1997 Jun; 74(3):335-45. PubMed ID: 9221815
[TBL] [Abstract][Full Text] [Related]
15. Heparan Sulfate Glycosaminoglycans in Glioblastoma Promote Tumor Invasion.
Tran VM; Wade A; McKinney A; Chen K; Lindberg OR; Engler JR; Persson AI; Phillips JJ
Mol Cancer Res; 2017 Nov; 15(11):1623-1633. PubMed ID: 28778876
[TBL] [Abstract][Full Text] [Related]
16. Acute UV irradiation increases heparan sulfate proteoglycan levels in human skin.
Jung JY; Oh JH; Kim YK; Shin MH; Lee D; Chung JH
J Korean Med Sci; 2012 Mar; 27(3):300-6. PubMed ID: 22379342
[TBL] [Abstract][Full Text] [Related]
17. In-Depth Matrisome and Glycoproteomic Analysis of Human Brain Glioblastoma Versus Control Tissue.
Sethi MK; Downs M; Shao C; Hackett WE; Phillips JJ; Zaia J
Mol Cell Proteomics; 2022 Apr; 21(4):100216. PubMed ID: 35202840
[TBL] [Abstract][Full Text] [Related]
18. Perlecan heparan sulfate proteoglycan is a critical determinant of angiogenesis in response to mouse hind-limb ischemia.
Qiang B; Lim SY; Lekas M; Kuliszewski MA; Wolff R; Osherov AB; Rudenko D; Leong-Poi H; Noyan H; Husain M; Tran K; Tryggvason K; Hedin U; Tran-Lundmark K; Strauss BH
Can J Cardiol; 2014 Nov; 30(11):1444-51. PubMed ID: 25249499
[TBL] [Abstract][Full Text] [Related]
19. Pentosan Polysulfate, a Semisynthetic Heparinoid Disease-Modifying Osteoarthritic Drug with Roles in Intervertebral Disc Repair Biology Emulating the Stem Cell Instructive and Tissue Reparative Properties of Heparan Sulfate.
Smith MM; Hayes AJ; Melrose J
Stem Cells Dev; 2022 Aug; 31(15-16):406-430. PubMed ID: 35102748
[TBL] [Abstract][Full Text] [Related]
20. Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders.
Farach-Carson MC; Warren CR; Harrington DA; Carson DD
Matrix Biol; 2014 Feb; 34():64-79. PubMed ID: 24001398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
